Synthesis and Pharmacological Evaluation of Some New 2-Phenyl benzimidazoles Derivatives and their Schiff's Bases
Author(s) -
Yashpal S. Chhonker,
B. Veenu,
Sahar Hasim,
Niranjan Kaushik,
Devendra Kumar,
Pradeep Kumar
Publication year - 2009
Publication title -
journal of chemistry
Language(s) - English
Resource type - Journals
eISSN - 2090-9063
pISSN - 2090-9071
DOI - 10.1155/2009/604203
Subject(s) - chemistry , bacillus subtilis , benzimidazole , antimicrobial , pseudomonas aeruginosa , staphylococcus aureus , bacteria , escherichia coli , gram , gram positive bacteria , reagent , gram negative bacteria , microbiology and biotechnology , organic chemistry , biochemistry , genetics , gene , biology
Some new 2- phenyl benzimidazole derivatives were synthesised by cyclocondensation with appropriate reagents. The compounds synthesised were identified by 1 H NMR, FAB Mass and FT-IR spectroscopic techniques. All compounds studied in this work were screened for their in vitro antimicrobial activities against the standard strains: Staphylococcus aureus ATCC - 25923, ATCC - 441 and Bacillus subtilis ATCC- 6633 as gram positive, Escherichia coli ATCC - 11775 and Pseudomonas aeruginosa ATCC 10145 as gram negative bacteria. Some of the compounds inhibited the growth of gram- positive bacteria ( B. subtilis and S. aureus ) at MIC values between 25 and 200 mg/mL. Some of the compounds exhibit antimicrobial activity against gram negative bacteria ( E. coli and P. Aeruginosa ) MIC values between 25 and 200 mg/mL.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom